Axon Enterprise, Inc. (NASDAQ:AXON) Shares Sold by International Assets Investment Management LLC

International Assets Investment Management LLC reduced its position in Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 99.8% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 485 shares of the biotechnology company's stock after selling 217,697 shares during the quarter. International Assets Investment Management LLC's holdings in Axon Enterprise were worth $289,000 as of its most recent filing with the SEC.

Several other large investors also recently modified their holdings of AXON. Insigneo Advisory Services LLC raised its holdings in shares of Axon Enterprise by 1.4% in the 3rd quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company's stock worth $627,000 after acquiring an additional 22 shares during the last quarter. Menard Financial Group LLC boosted its position in Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company's stock worth $1,204,000 after purchasing an additional 24 shares during the last quarter. PFG Investments LLC raised its stake in shares of Axon Enterprise by 0.6% during the 3rd quarter. PFG Investments LLC now owns 3,872 shares of the biotechnology company's stock worth $1,547,000 after purchasing an additional 25 shares during the period. Gladstone Institutional Advisory LLC grew its position in shares of Axon Enterprise by 1.6% during the 3rd quarter. Gladstone Institutional Advisory LLC now owns 1,641 shares of the biotechnology company's stock valued at $656,000 after acquiring an additional 26 shares during the period. Finally, Mather Group LLC. lifted its stake in shares of Axon Enterprise by 3.7% during the 3rd quarter. Mather Group LLC. now owns 759 shares of the biotechnology company's stock valued at $303,000 after buying an additional 27 shares in the last quarter. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other news, President Joshua Isner sold 20,000 shares of the business's stock in a transaction that occurred on Tuesday, November 12th. The stock was sold at an average price of $606.15, for a total transaction of $12,123,000.00. Following the transaction, the president now directly owns 208,166 shares in the company, valued at $126,179,820.90. The trade was a 8.77 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of Axon Enterprise stock in a transaction that occurred on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the sale, the director now directly owns 6,929 shares in the company, valued at approximately $4,185,601.03. The trade was a 6.10 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 51,545 shares of company stock worth $31,159,317 over the last 90 days. Company insiders own 6.10% of the company's stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on AXON shares. Morgan Stanley upgraded shares of Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Northland Securities raised their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. Needham & Company LLC raised their target price on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a research note on Friday, November 8th. TD Cowen assumed coverage on Axon Enterprise in a research report on Wednesday, January 8th. They set a "buy" rating and a $700.00 price target for the company. Finally, The Goldman Sachs Group lifted their price objective on Axon Enterprise from $385.00 to $441.00 and gave the stock a "buy" rating in a research report on Wednesday, October 23rd. One analyst has rated the stock with a hold rating and fourteen have given a buy rating to the company. According to MarketBeat.com, Axon Enterprise currently has a consensus rating of "Moderate Buy" and an average target price of $504.92.

Axon Enterprise Trading Down 1.3 %

Shares of NASDAQ AXON traded down $7.62 during mid-day trading on Monday, reaching $562.38. The company had a trading volume of 90,874 shares, compared to its average volume of 665,732. The stock has a market cap of $42.88 billion, a price-to-earnings ratio of 145.32, a price-to-earnings-growth ratio of 14.19 and a beta of 1.04. The company has a current ratio of 2.96, a quick ratio of 2.63 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 52 week low of $246.99 and a 52 week high of $698.67. The business's 50-day moving average is $607.29 and its 200-day moving average is $451.03.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.